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ABSTRACT 
Background: Adequate dietary intakes of vitamin A are protective against lung cancer, but little 
is known about the risk of lung cancer when intakes of the vitamin are below minimum 
physiological requirements. Further investigation into this relationship is needed considering 
established relationships between smoking, vitamin A deficiency (VAD), and lung cancer risk. 
Objective: The objective of this study was to determine whether intakes of vitamin A below the 
minimal physiological threshold increased the likelihood of lung cancer. We hypothesized 
vitamin A intakes above the minimal physiological threshold would reduce the likelihood of lung 
cancer. Methods: A case-control approach was used, utilizing data from eight cycles of 
NHANES surveys. Cancer-free, everyday cigarette smokers were matched on a 1:1 basis to cases 
with lung cancer by smoking duration, sex, and age. Paired sample T-tests were used to test 
differences in mean intakes of retinoids between groups, while an Exact McNemar test was used 
to assess differences between categorical variables. Conditional logistic regression was used to 
model the relationship between vitamin A insufficiency and lung cancer incidence, before and 
after adjustment. Results: A covariate in our adjusted model, milk consumption was significantly 
associated with increased odds of lung cancer (OR = 2.38, CI = 1.04 – 5.43). Contrary to our 
hypothesis, intakes of vitamin A at or above the minimal physiological threshold increased the 
odds of lung cancer, though confounding effects of several covariates, such as the age of 
smoking initiation, could not be ruled out (OR = 5.49, CI = 0.82 – 36.96). Conclusions: While 
mean intakes of vitamin A and subtypes did not significantly differ between case and control, 
only 20.4 % of individuals across our sample consumed intakes at or above gender-specific 
RDAs. As we did not collect data on food-specific micro/macronutrients, more research into 
dietary contributions of micro/macronutrients from foods known to be implicated in lung cancer 
prevention or risk, such as vitamin A, vitamin A, calcium, and fatty acids, could prove to be 
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CHAPTER 1: REVIEW OF THE LITERATURE 
1. Vitamin A Sources, Metabolism and Biological Function  
Vitamin A is an essential, fat-soluble vitamin responsible for cell/tissue growth and 
differentiation, vision, epithelial integrity, reproduction, and immune system health 1-3. In 
foods, vitamin A is largely found in two forms; as retinyl esters in animal sources and as 
pro-vitamin A carotenoids in plant sources, with the former known as preformed vitamin 
A. Collectively, the different forms of vitamin A and its metabolites within the body are 
known as retinoids 4. Common sources of preformed vitamin A include liver, egg yolks, 
and fortified dairy products such as cow’s milk. Common sources of provitamin A 
carotenoids include sweet potatoes, green leafy vegetables, and carrots 4. 
Both preformed vitamin A and carotenoids are absorbed into the intestinal epithelium, 
converted into retinyl esters, and exported into the lymphatic circulation within 
chylomicrons, which subsequently travel into mainstream circulation. Some of the esters 
are transferred to specific target tissues and the other retinyl esters remain within the 
remnants of chylomicrons that are eventually taken up by the liver, where they are stored 
or hydrolyzed into free retinol 5. In the liver, vitamin A is stored as retinyl esters where 
they coalesce to form lipid droplets in storage cells, known as stellate cells. Upon 
hydrolysis of these stored retinyl esters, retinol is released into the plasma via a transport 
protein known as retinol-binding protein (RBP); Transthyretin (TTR) attaches to RBP in 
the plasma, preventing its excretion by the kidneys. The RBP-TTR complex transits the 
bloodstream where its retinol is taken up by target cells expressing the RBP receptor. 




Much of retinoic acid’s biological activity can be traced to its interaction with various 
nuclear receptors, Retinoic Acid Receptors (RAR) and Retinoid X Receptors (RXR). 
Briefly, upon being shuttled to the nuclear envelope, retinoic acid can interact with these 
receptors by binding to them, causing conformational changes and, in many cases, 
dimerization with other receptors; a heterodimeric receptor can then bind to DNA at 
specific response elements. Next, these response elements act in a specific way to 
influence basal transcription or chromatin remodeling, actions that are dependent on the 
coactivator(s) attached to the dimerized receptors 9, 10. Many of vitamin A’s necessary 
functions can be traced through this genomic activity. 
2. Vitamin A Deficiency  
2.1. General Deficiency  
VAD is a serious threat to human health; its wide range of physiological functions 
means that in the absence of the vitamin a wide range of physiological processes are 
disrupted. Collectively, the wide range of symptoms associated with VAD are known as 
vitamin A Deficiency Disorders or VADD. Along with protein-energy malnutrition, 
VADD constitutes the world’s most common nutritional deficiency 11, 4. Clinical 
manifestations of the deficiency include night blindness, dry skin, and abnormal 
keratinization of mucosal epithelial surfaces, such as those found in the respiratory, 
genitourinary, gastrointestinal tracts, and cornea 4,12. 
In addition to the spectrum of physiological issues VAD causes, maternal VAD appears 
to have grave consequences on embryonic organ development, likely due to the role of 
retinoids in regulating cell/tissue differentiation and development; researchers 
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manipulated doses of dietary vitamin A in pregnant rats to mimic maternal VAD and 
found that the offspring of vitamin A deficient mothers exhibited severe congenital 
malformations of the eyes, diaphragm, vasculature, and lungs 13. In contrast, in humans, 
in a small sample of Egyptian pregnant women, newborns delivered from mothers with 
VAD had significantly smaller kidneys compared to those newborns which were 
delivered from vitamin A sufficient mothers 14. Additional roles of retinoids in the 
developing embryo include neural development, epithelial differentiation, craniofacial 
morphogenesis, and squamous epithelial maintenance 15. 
2.2. Deficiency Impacting the Lung 
Lung development is a tightly regulated process and retinoic acid (RA) plays an 
important role in this development. RA coordinates pathways responsible for the genesis 
of lung budding and regulates alveologenesis largely through RAR activity. 
Additionally, RA promotes septation, smooth muscle differentiation, and development, 
and plays an important role in maintaining lung function 16-18. Consequently, VAD can 
pose disastrous effects on lung development; in newborn rats, mild VAD induced lower 
lung weights, lower alveoli septic thickness, and lower total alveoli numbers compared 
to those which received normal diets 19. Rats fed a vitamin A-free diet gave birth to rats 
that exhibited impaired lung growth and development, as well as compromised vital 
organs such as the heart, liver, and kidney 20. In populations at risk for VAD and general 
undernourishment, children with mothers who consumed adequate amounts of vitamin A 
before, during, and post-pregnancy had better lung function than those children of 
mothers who consumed a vitamin A-deficient diet during the same period. Subtle defects 
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in lung development, from VAD or other means, can impact long-term health outcomes 
of organs and structures of the pulmonary system, like the lungs and alveoli 21, 22.  
In addition to causing developmental issues with and within the lung, VAD appears to 
impact the risk of developing certain conditions affecting the lung as well, such as 
asthma and emphysema, while increasing the risk of developing certain infections 23. 
Vitamin A plays an important role in immune system function and as such, an absence 
or reduced amount of it may increase the susceptibility to certain infections 23. In a 
population of rural Indonesian children, VAD was found to be closely correlated with an 
increased risk of respiratory disease and diarrhea 24. In a recent meta-analysis analyzing 
micronutrient supplementation and risk of various infant infections, vitamin A appeared 
to exert a protective effect against certain infections, such as measles and 
bronchopneumonia but failed to show any protective effect against generalized 
pneumonia 25. A randomized controlled trial found lower serum vitamin A levels in 
children with stable asthma compared to healthy children, while a high intake of fruits 
and antioxidants, as well as adherence to the Mediterranean diet (which is rich in 
provitamin A carotenoids), was associated with a decreased incidence of asthma 26. 
Another study analyzing the relationship between VAD and symptoms of respiratory 
distress in infants found a positive association between the severity of VAD and the 
severity of wheezing 27. Further, airway hyperresponsiveness (AHR) was found to be 
enhanced in rats fed a vitamin A-deficient diet; the AHR returned to normal after 12 
days of RA administration 28. 
VAD has also been shown to induce conditions in the lungs of rats similar to that of 
emphysema with reduced lung elastin content and decreased type II pneumocyte 
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surfactant synthesis; this is likely due to RA’s role in alveolar regeneration and tissue 
repair 29. Damage to the oxidant/antioxidant balance of the lung through oxidative stress 
is also thought to be an important contributor to the development of emphysema, an 
event that often occurs in tobacco smokers 11. Specifically, cigarette smoke oxidatively 
damages the alpha-1 antitrypsin inhibitor, a compound that inhibits the activity of the 
enzyme elastase; elastase activity substantially increases, causing a breakdown in 
alveolar elastin and leading to impaired lung function 30. While VAD contributes to 
conditions in the rat lung which increase the risk for emphysema, cigarette smoke 
inhalation has been shown to deplete lung vitamin A content, further contributing to the 
development of emphysema 30. Emphysema, along with chronic bronchitis, comprises a 
condition known as COPD (Chronic Obstructive Pulmonary Disease); importantly, 
COPD is thought to be one of the most significant risk factors in lung cancer 
development and smokers who develop COPD have a greater risk of lung carcinogenesis 
compared to smokers who do not develop COPD 31, 11. Thus, a relationship between 
cigarette smoke inhalation and VAD may account for a significant portion of 
emphysema development in animal models, while also impacting the risk of COPD 
development and, subsequently, lung cancer. 
3. Lung Cancer and Vitamin A 




Many fruits and vegetables like sweet potatoes, butternut squash, spinach, oranges, and 
carrots are high in provitamin A carotenoids 4. Epidemiological evidence shows 
increased fruit/vegetable intake to be associated with decreased risk of some cancers; 
High fruit and vegetable intakes are associated with a lower risk of colon cancer 32. 
Increased consumption of fruits and vegetables is associated with a reduced risk of 
extrahepatic bile duct cancer and a small reduction in prostate cancer risk has been 
shown with higher fruit intake 33, 34. Additionally, increased consumption of Vitamin C-
rich vegetables was shown to decrease the risk of prostate cancer 35. Amongst the 
elderly, supplemented vitamins A and C were shown to reduce colon cancer risk in 
women 36. In men, decreased risk of renal cell cancer was associated with consumption 
of fruits and vegetables while intakes of vitamin A, C, and carotenoids from food were 
inversely associated with renal cell cancer risk 37.  
 
As retinoic acid (RA), vitamin A has shown therapeutic promise in treating a form of 
cancer known as acute promyelocytic leukemia (APL) 38. In combination with 
chemotherapeutic compounds such as arsenic trioxide (ATO), ATRA (all-trans retinoic 
acid) has been shown to lead to complete remission in 93% of patients and 5-year 
survival rates close to 100% 39. Such effects have been observed to occur independently 
of ATO as well; Huang et al (1988) showed that ATRA (All-trans-retinoic acid) 
administration induced remission in 24 out of 24 cases of APL 40. Evidence for ATRA 
having a protective role in other forms of cancer, however, is largely limited to in vitro 
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studies; ATRA has been shown to inhibit the growth of colorectal cancer cells and arrest 
the growth of cancer cells in prostate cancer cell culture 41.  
Clinical trials investigating RA’s effects on other forms of cancer have been less fruitful, 
due to a limited number of studies on the topic 42. In vivo, RA’s effectiveness on several 
different cancers, such as lung cancer, are mixed; this is likely due to RA’s accelerated 
degradation with continuous administration 43. Recent research has shown, however, that 
lipid-encapsulated RA formulas exhibit promising therapeutic benefits in treating lung 
cancer, compared to RA taken alone. In rats injected with lung cancer cell lines, ATRA 
encapsulated in a liposome consisting of phosphatidylcholine and cholesterol increased 
lifespan and reduced tumor module formation, compared to rats injected with ATRA 
only. Further, lung tissue of the rats given ATRA suspended in the liposome had 
significantly greater concentrations of ATRA; the authors of this study posited that the 
corresponding increase in ATRA in lung tissue could have been a product of increased 
transcription of RARs, some of which have been shown to have anti-cancer properties, 
such as RAR-Beta 44. 
3.2. Dietary Vitamin A Intake, Supplemental Retinoid Intake, and Lung Cancer Risk 
Outside of RA, several meta-analyses and studies have documented protective effects of 
fruit and vegetable intake, as well as dietary vitamin A/pro-vitamin A carotenoids on 
lung cancer risk. In a study examining the effects of individual Dietary Inflammatory 
Index (DII) and the Mediterranean Diet Score (MDS) on lung cancer risk, it was found 
that a higher MDS was inversely associated with lung cancer risk. A Mediterranean diet 
is often rich in vitamin A and pro-vitamin A carotenoids 26, 45. Similarly, it has been 
shown that several dietary antioxidants, most notably vitamin C and pro-vitamin A 
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carotenoids, exert a protective effect against lung cancer in both moderate and heavy 
smokers 46. A meta-analysis of 18 studies investigating fruit and vegetable consumption 
and comparative lung cancer risk found similar results; higher intakes of fruits and 
vegetables were shown to contribute an 8-18% lower risk of lung cancer in smokers 47. 
Similarly, in a meta-analysis pooling 19 studies, it was found that higher intakes of foods 
containing beta-carotene and vitamin A were associated with decreased lung cancer risk 
48. 
While dietary intakes of vitamin A and/or antioxidant-rich fruits and vegetables may 
reduce the risk of lung cancer in both smokers and non-smokers, another important 
source of vitamin A in the American diet is cow’s milk. While milk consumption in the 
US has decreased over the past few decades, the average American in 2018 drank around 
17 gallons a year 49. Thus, it is likely that milk is a substantial contributor to overall 
vitamin A sufficiency in the American diet. Generally, intakes of milk and dairy 
products are associated with improved health/disease outcomes 50. Interestingly, 
evidence for milk consumption and lung cancer risk point to protective effects in some 
cases, and increased risk in other cases. In Sweden, a case-control study in patients with 
suspected lung cancer found an overall protective effect of vegetable intake but an 
increased risk of lung cancer with increasing milk consumption 51. Investigators in the 
Guangzhou Biobank Cohort Study found that in individuals 50 years or older, moderate 
milk consumption was associated with lower cardiovascular disease mortality but high 
milk consumption was associated with a higher risk of total cancer mortality 52. A 
hospital-based case-control study analyzing dietary habits of lung cancer patients found 
a 2-fold increase in lung cancer risk in patients who reported consuming whole milk 
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three or more times daily, compared to those who never drink milk. In this same study, a 
reduction in lung cancer risk was noted in individuals who consumed 2% or reduced-fat 
milk 53. Compared to the observed protective effect of lung cancer in individuals who 
consume large amounts of fruits and vegetables, the effect of milk consumption on lung 
cancer risk is far less clear. 
Outside of diet-based retinoid consumption, investigators have studied the effects of 
supplemental retinoids on lung cancer risk since the 1990s, with results pointing to a 
pronounced increase in lung cancer risk/incidence in smokers 11, 54, 55. In ferrets exposed 
to cigarette smoke, supplemental carotenoids have been shown to increase lung cancer 
risk 55. In the Beta-Carotene and Retinol Efficacy Trial, 18,314 smokers, former 
smokers, and workers exposed to asbestos were given a combination of supplemental 
beta-carotene and retinyl palmitate. The risk of lung cancer in those receiving 
supplements was drastically larger than those receiving the placebo; as such, the trial 
was stopped 21 months early 54. As this result has been reproduced in several other large, 
interventional trials, the American Institute for Cancer Research (AICR) has labeled 
beta-carotene supplement use in smokers and former smokers as a cause of lung cancer 
11. The effects of supplemental beta-carotene on lung cancer risk have been hypothesized 
to be the product of an interaction between the supplement and cigarette smoke; a pro-
oxidant effect of the cigarette smoke may lead to a free radical-induced transformation 
of beta-carotene to a structurally similar, yet biologically inert retinoid 11, 55. Of note, 
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such an effect does not explain the increased risk of lung cancer observed in former 
smokers receiving beta-carotene supplements. 
3.3. VAD, Cigarette Smoke, and Lung Cancer  
In the United States alone, lung cancer is the second most common form of cancer in 
both men and women, with a combined 228,150 new cases appearing in 2019. It’s also 
the most lethal form of cancer in both males and females, with estimated mortality rates 
of 24% and 23%, respectively; non-specific symptoms associated with cancer may 
contribute to this high mortality rate 56, 57. The pathogenesis of lung cancer is complex, 
with roots in both genetics and environmental toxins. Furthering this complexity, the 
type of lung cancer may differ based on exposure to a specific carcinogen 58. Of known 
risk factors for lung cancer development, tobacco smoke inhalation is the most 
prominent with an estimated 90% of new cases of lung cancer in some countries 
attributable to it 59. 
The relationship between cigarette smoke and VAD is clearer than that of VAD and lung 
cancer risk. Almost three decades ago, researchers showed that benzopyrene-enriched rat 
feed induced a localized depletion of retinol in both the lung and the liver but not the 
serum of rats, pointing towards a potential role of vitamin A in protecting against lung 
cancer 60. Later, researchers showed marked damage to both the liver and lungs when 
VAD was induced through the diet. In this model, the damage to the lungs mirrored that 
of emphysema 29. As discussed in the previous section, emphysema in combination with 
chronic bronchitis results in a condition known as COPD. COPD is a significant risk 
factor for the development of lung cancer 31. Subsequently, researchers showed that lung 
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retinoic acid content is depleted in rats exposed to cigarette smoke, with the tracheal 
tissue developing precancerous lesions 30.  
Though cigarette smoke contributes to lung VAD it also contributes to cancer risk 
through the expression of proteins related to both vitamin A metabolism and cancer; 
lung retinoic acid content was depleted when rats were exposed to cigarette smoke 
which was correlated with a decrease in the expression of Retinoic Acid Receptor Beta 
(RAR-Beta), a protein implicated in decreased cancer risk 61-63. Furthermore, many 
proteins associated with cancer growth were upregulated. Retinoic acid given to rats has 
been shown to down-regulate many proteins associated with cancer, even in the presence 
of cigarette smoke 63.  
Independent of cigarette smoke, emerging evidence points to VAD increasing the 
expression of proteins linked to EMT (Epithelial-Mesenchymal Transition), a key stage 
in the progression and severity of respiratory pathologies such as COPD, pulmonary 
fibrosis, and lung cancer 64, 11. Broadly, EMT occurs when epithelial cells lose proteins 
specific to their phenotype and gain proteins similar to a mesenchymal cell phenotype. 
While this transformation is characteristic of normal physiological processes such as 
those that occur during embryonic development and inflammation, its occurrence during 
lung carcinogenesis reduces the adherence capacity of cancer cells and increases the 
likelihood of metastasis to underlying tissues 64, 65. The Notch signaling pathway is 
intimately involved in EMT progression, particularly as it pertains to the cell-specific 
transition to a mesenchymal phenotype in the tumor microenvironment 66. Key to the 
involvement of Notch in this process is its interaction with Transforming Growth Factor-
B1. Interestingly, VAD has been shown to increase the expression of Transforming 
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Growth Factor-B1 in animal models, pointing to a potential downstream relationship 
between VAD and EMT 67. Down-regulation of proteins involved with cell-cell junction 
integrity and subsequent dissociation of these cell-cell junctions is a hallmark of the 
beginning stages of EMT. One such protein is E-cadherin, a protein that is also 
downregulated in cellular models of VAD 11, 64. ATRA has been shown to activate E-
cadherin expression as well as downregulate levels of Vimentin and Fibronectin in 
human colon carcinoma cells, pointing to a potential therapeutic mechanism for 
inhibiting EMT in certain forms of cancer 68. Overall, the relationship between VAD and 
the EMT in lung cancer cells represents a promising avenue of research for the 
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CHAPTER 2: BODY OF THESIS 
1. Introduction  
Vitamin A plays a crucial role in cell/tissue growth and differentiation, cell signaling, 
reproduction, epithelial integrity, vision, and maintenance of the immune system, across 
all stages of life 1, 2. Vitamin A Deficiency (VAD), particularly during periods when the 
body undergoes rapid growth, is detrimental because of its complex role in important 
bodily processes such as vision, epithelial integrity, and immune function; as such, VAD, 
especially in children, can lead to preventable blindness and increased risk of death from 
respiratory infections 3,4. Impairments to the respiratory tract and associated organs are 
established consequences of VAD 5. VAD has been shown to cause profound 
morphological changes to both the rat lung and liver, impairing pneumocyte function, 
surfactant production, and promoting inflammation 6. Additionally, increased rates of 
respiratory infections, increased risk of asthmatic symptoms, and increased risk of 
emphysema are often observed in conditions where VAD is present 2, 7, 8. Additionally, 
VAD may increase the risk of developing emphysema, COPD, and lung fibrosis, 
particularly in smokers 5. 
Unlike pathologies such as emphysema, asthma, and lung fibrosis the involvement of 
VAD in the etiology of lung cancer is not as clear. Lung cancer is the second most 
common form of cancer in the US and is also the most lethal 9. Inhalation of tobacco 
smoke is the most well-known risk factor for lung cancer development 10. The 
development of lung cancer (lung carcinogenesis) in tobacco smokers is thought to be 
largely attributable to a combination of oxidative/free radical damage and DNA damage, 
particularly in the form of DNA adducts and their metabolites 11. Over the past decades, 
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emerging evidence has pointed to an interaction between cigarette smoke and vitamin A 
in the lung; inhalation of cigarette smoke in animals has shown to induce VAD in the 
lungs and increase lung cancer risk 12. Further, VAD induced by cigarette smoke has also 
been shown to lead to the formation of pre-cancerous, tracheal lesions and has been 
shown to deplete lung retinoic acid content while increasing cancer risk through the 
expression/suppression of certain cancer-related proteins 12, 13. Independent of cigarette 
smoke, VAD alone is being investigated for its potential role in a process known as 
Epithelial-Mesenchymal Transition, or EMT 5. EMT increases the likelihood of 
established cancer to invade underlying tissues; VAD impacts several proteins implicated 
in both signaling and structural components of the process such as the Notch signaling 
pathway, Transforming Growth Factor-B1, and e-Cadherin 14-17. Combined with the 
established pathophysiology of cigarette smoke, VAD in pulmonary tissue has shown and 
is continuing to show evidence that may link it to a contributory role in lung 
carcinogenesis. 
In contrast to VAD, the relationship between adequate dietary intakes of vitamin A and 
lung cancer has been studied extensively, albeit observationally. Recent epidemiological 
evidence indicates that diets rich in fruits and vegetables, especially those containing 
provitamin A carotenoids and other antioxidants, reduce the risk of lung cancer in the 
general population as well as heavy and moderate smokers 18, 19. Elsewhere, recent meta-
analyses showed reductions in lung cancer risk amongst current smokers, but not former 
and never smokers, as well as reductions in lung cancer risk with increasing intakes of 
beta-carotene from the diet in the general population 20, 21. While intakes of fruits and 
vegetables rich in the provitamin A carotenoids and other antioxidant nutrients may 
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reduce lung cancer risk in smokers, intakes of fruits and vegetables amongst smokers are 
lower compared to non-smokers 22. 
While cigarette smoke-induced VAD increases the risk for lung cancer in animal models, 
it is unclear as to what extent VAD contributes to the increased cancer risk in humans 23. 
Though adequate dietary vitamin A is broadly protective against lung cancer, there is 
limited evidence available to determine what extent intakes of the vitamin lower than the 
minimal physiological requirements to prevent deficiency affect lung cancer risk. Thus, 
we sought to investigate this relationship through a retrospective cohort study derived 
from NHANES data. Our working hypothesis is that localized depletion of lung vitamin 
A by cigarette smoke may contribute to lung carcinogenesis through physiological 
changes as well as changes to the microcellular environment; consequently, 
insufficient/very low dietary vitamin A intake from food may expedite this process in 
individuals who smoke cigarettes. Contrarily, intake of abundant vitamin A from the diet 
may delay lung carcinogenesis in smokers. 
Through a case-control design, we looked at individuals with lung cancer matched to 
cancer-free controls with similar histories of cigarette smoking. To our knowledge, no 
existing case-control studies have examined the relationship between dietary retinoid 
intakes and lung cancer risk, using smoking duration as the primary matching criteria. 
Further, we are unaware of any studies that have looked at lung cancer incidence and its 
association with dietary vitamin A intakes by classification of less than or greater than 
gender-specific, minimal physiological requirements. By using such criteria, we hoped to 
discover whether rates of vitamin A insufficiency differed significantly between case and 
control, given similar smoking history. Through this, we aimed to determine whether 
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intakes of retinoids lower than established minimum requirements could increase the risk 
of lung cancer.  
2. Methods 
2.1. Data Collection 
Participants were selected from eight cycles (2003/2004 – 2017/2018) of the National 
Health and Nutrition Examination Survey (NHANES). A function of the National Center 
for Health and Statistics (NCHS), the NHANES is a cross-sectional survey designed to 
analyze trends in the health and nutritional status of adults and children across the US 24. 
Information is collected through physical examinations, interviews, questionnaires, and 
laboratory analyses. Information collected includes, but is not limited to dietary intakes, 
laboratory values, smoking habits, demographic information, anthropometric 
measurements, medical history, medication/supplement use, and dental health. 
NHANES is designed to collect information that is nationally representative of the 
United States civilian (non-institutionalized) population. As such, data is collected 
through a four-stage sampling procedure each cycle, across 15 different national 
locations. New surveys are collected every 2 years and consist of approximately 10,000 
individuals a survey. Each cycle, certain subsets of the population who are of public 
health interest are oversampled to produce estimates representative of the non-
institutionalized, US population 25. The NHANES protocol was approved by the NCHS 
Ethics Review Board. Further, participants had to provide signed, written consent to be a 
part of NHANES data collection. As our study was a secondary analysis using de-
identified personal data, it did not require Institutional Review Board (IRB) review. All 
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data collected as part of our study is publicly available at 
https://www.cdc.gov/nchs/nhanes/.   
2.2. Research Design  
A case-control approach using pairwise, 1:1 matching of the case to control was used to 
investigate whether insufficient dietary vitamin A increases the risk for lung cancer and 
whether sufficient dietary intakes are protective against lung cancers in current smokers. 
Broadly, a case-control study design uses a preselected group of cases with an outcome 
of interest, along with a control group constructed similarly to the case group but without 
the outcome of interest. Following this, researchers can compare exposures across 
groups to determine whether certain risks are more common in one group versus the 
other 26. Our case-control approach was advantageous for our research question because 
the number of lung cancer cases was low in our initial sample  26. This approach allowed 
us to evaluate our target population efficiently, albeit retrospectively. Further, case-
control approaches help assess the impact of multiple risk factors on a target outcome at 
once as well as potential factors that could decrease the risk of the outcome as well. 
Thus, our design allowed us to explore the impact of various factors on the outcome and 
assess their independent and collective contributions to lung cancer risk 26. This helped 
us answer our research questions and determine the sample-specific etiology of lung 
cancer risk. For more details concerning the construction of the case and control groups, 
as well as details concerning our matching process, please see Figure 1 and section 2.4, 
30 
 
“Exclusion Criteria and Group Selection”. Specifics concerning variables of interest and 
our outcome can be found in Table 1 as well as section 2.3, “Variable Selection”. 
2.3. Variable Selection  
Table 1 outlines variables of interest in our investigation, as well as cycle by cycle 
changes in question formatting or coding in the NHANES data files. Table 2 outlines 
changes made to the coding or output of variables of interest, as well as transformations 
made to the variables. Variables of interest in our study were chosen for their 
importance/relationship to the primary outcome and our investigation of influential 














Figure 1  
 





















Variables of Interest for Case/Control Establishment, Exclusion Criteria, and Statistical Analysis  
 
Variable Name/Code Variable Location 
Within NHANES 
Cycle File Answer Choices Cycle Changes 
 
MCQ240N – “Age 







If answered, age of 




Instead of asking 




about their 1st, 2nd, 





RIDAGEYR – “Age in 
































categories) based on 







BMXWAIST – “Waist 
Circumference (cm)” 
 








HUQ050 – “#Times 
Receive Healthcare 








categories) based on 
the range of times 







“USDA Food Code” 
 
Dietary Interview – 
Individual Foods, 
First Day & Second 
Day 
 
Food Codes were 
provided based on 








Cycle to cycle 















DR1+2TRET – “Retinol 
(mcg)” 
DR1+2TP182 – “PFA 
18:2 (Octadecadienoic) 
(gm)” 
DR1+2TP183 – “PFA 
18:3 (Octadecatrienoic) 
(gm)” 
DR1+2TP205 – “PFA 
20:5 (Eicosapentaenoic) 
(gm)” 






Dietary Interview – 
Total Nutrient 




intakes are provided 
numerically, based 







DR1+2300 – “Compare 
food consumed 
yesterday to usual” 
 
Dietary Interview - 
Total Nutrient 
Intakes, First & 
Second Day 
 
Whether or not 
intakes from 24-hr 
recalls are similar to 








Supplement ID Number 
 
Dietary Supplement 









during the in-home 
interview portion of 
NHANES. 
 
In 2003-2006 (two 
cycles), supplement 
ID codes and 
supplement names 




Day - File 2, 




Database - Product 
Information” and 
had to be matched 
before usage. 
 








a frequency of milk 
product 
consumption over 
the past 30 months, 
with choices from 0 










Use – Adult 
 
Individuals list age 
and if never smoked 
regularly, “0” 
 
After the 2003-2004 
Cycle, the Title of 
the Dataset changed 
to “Smoking – 
Cigarette Use” to 
encompass all age 
groups of 
participants. 
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Use – Adult 
Individuals choose 
between “Every 
day”, “Some days”, 
or “Not at All” 
After the 2003-2004 
Cycle, the Title of 
the Dataset changed 
to “Smoking – 
Cigarette Use” to 




SMQ050Q – “How long 
since quit smoking 
cigarettes” 
& 






Use – Adult 
 
Individuals choose a 
value and 






After the 2003-2004 
Cycle, the Title of 
the Dataset changed 
to “Smoking – 
Cigarette Use” to 










Use – Adult 
 
Participants list a 
numerical value for 
this question. 
 
After the 2003-2004 
Cycle, the Title of 
the Dataset changed 
to “Smoking – 
Cigarette Use” to 




SMD057 – “# cigarettes 





Use - Adult 
 
Participants list a 
numerical value for 
this question. 
 
After the 2003-2004 
Cycle, the Title of 
the Dataset changed 
to “Smoking – 
Cigarette Use” to 






SMD070 – “# cigarettes 




Use - Adult 
 
Participants list a 
numerical value for 
this question. 
 
After the 2003-2004 
Cycle, the Title of 
the Dataset changed 
to “Smoking – 
Cigarette Use” to 




SMD410 – “Does 











Note: In their original format, dietary variables associated with the first recall day were indicated 
by “DR1_” followed by the specific food or nutrient. Dietary variables associated with the 
second recall day were indicated by “DR2_”. For the sake of organization and space, we 
indicated any dietary variables which were recorded for both recall days as “DR1+2”, followed 
by the original food/nutrient code. For example, the DR1+2TVARA – “Vitamin A, RAE (mcg)” 










Variables transformed or recoded for analysis 
 
Original Variable(s) Summary of Changes New Variable 
 
DR1+2TVARA – “Vitamin 












Summed two-day recall 
totals of each retinoid and 
provitamin A carotenoid 
together then divided the 
value by two to produce an 
average for each participant. 
 
“Mean Two-Day Total 
Vitamin A Intakes” 
“Mean Two-Day Total 
Retinol Intakes” 
“Mean Two-Day Total Beta 
Carotene Intakes” 
“Mean Two-Day Total Alpha 
Carotene Intakes” 




“Mean Two-Day Total Beta 
Carotene Intakes” 
“Mean Two-Day Total 
Alpha Carotene Intakes” 





Produced a total carotenoid 
intake variable by adding all 
intakes of carotenoids for 
each participant together. 
 









DR1+2TP182 – “PFA 18:2 
(Octadecadienoic) (gm)” 
DR1+2TP183 – “PFA 18:3 
(Octadecatrienoic) (gm)” 
DR1+2TP205 – “PFA 20:5 
(Eicosapentaenoic) (gm)” 




Summed two-day recall 
totals of each fatty acid 
together then divided the 
value by two to produce an 
average for each participant. 
Following this, merged each 
new value into a “Sum” 
variable, which accounted for 




“Mean Two-Day Total 
Omega 6 Intakes” 
“Mean Two-Day Total 
Omega 3 Intakes” 
 
“Mean Two-Day Total 
Omega 6 Intakes” 
“Mean Two-Day Total 
Omega 3 Intakes” 
 
Created a ratio using mean 
Omega 3 Intakes and mean 
Omega 6 Intakes. 
 
Calculated Omega 6:3 Fatty 
Acid Ratio 
 
“Mean Two-Day Total 
Vitamin A Intakes” 
 
Classified individuals based 
on WHO recommendations 
for minimum vitamin A 
requirements, considering 
gender-specific requirements. 
Women who consumed less 
than 500 mcg a day were 
considered “Insufficient” 
while men who consumed 
less than 625 mcg a day were 
considered “Insufficient”. 
Sufficiency was coded as “1” 




Vitamin A Intakes” 
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MCQ240N – “Age When 
Lung Cancer First 
Diagnosed” 
 
A lung cancer diagnosis was 
considered if a participant 
had indicated an age for this 
variable. For the 2017-2018 
variables, a response was 
considered a diagnosis if an 
individual had filled out a 
response for 1st cancer 
diagnosis. Collectively, these 
responses were aggregated 
and transformed into a binary 
variable. Individuals with 
cancer were considered “1” 
and individuals without were 
considered “2”. 
“Ever Been Diagnosed With 
Lung Cancer or 
Malignancy?” 
 
DMEDUC2 – “Education 
Level – Adults 20+” 
 
 
Previously an ordinal 
variable with greater than 5 
levels, this variable was 
recoded to consider 
individuals with either a high 
school diploma or greater (1), 
or less than a high school 
diploma (2). 
 
“Education Level Highschool 
Diploma or Greater” 
 
SMD057 – “# cigarettes 
smoked per day when quit” 
 
SMD070 – “# cigarettes 
smoked per day now” 
 
A variable was created to 
combine both smokers and 
non-smoker cigarette per day 
intake. Reports of current 
smokers and former smokers 
were aggregated into one, 
continuous variable. 
 
“Cigarettes Per Day” 
 




For current smokers, the 
variable “Age started 
smoking cigarettes regularly” 





SMQ050Q – “How long 
since quit smoking 
cigarettes” 
& 




SMD055 – “Age last 
smoked cigarettes 
regularly” 
RIDAGEYR – “Age in 
Years at Screening” 
variable “Age in Years at 
Screening” to determine how 
long an individual had been 
smoking cigarettes. For non-
smokers, the age at which an 
individual started smoking 
regularly was subtracted 
from the age last smoked 
cigarettes regularly. 
Together, these values were 
aggregated into a separate 
variable and considered 
“Smoking Duration”. 
 
DR1+2IFDCD – “USDA 
Food Code” 
 
This variable was used to 
create four new variables. 
First, milk drinkers were 
sought out by looking at the 
food codes of individuals in 
the sample. After being 
identified, the type of milk 
was categorized from the 
food codes. Following this, a 
“Drink Milk?” variable was 
created with milk drinkers 
identifying as “1” and non-
drinkers identifying as “2”. 
This was carried out with 
three other variables 
comparing whole milk 
drinkers to everyone else, 2% 
drinkers to everyone else, 




“Two Percent Consumption 
vs. Everyone Else” 
“Whole Milk Consumption 
vs. Everyone Else” 
“Two Percent and Whole 
Milk Consumption vs. 
Everyone Else” 
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DBQ197 – “Past 30-day 
milk product consumption” 
Individuals who consumed 
moderate to frequent 
amounts of dairy products 
over the past 30 days were 
coded as “1” while everyone 
else was classified as “2”. 
“Moderate-Frequent Milk 
Consumption vs. Everyone 
Else” 
 





were organized into sex-
specific categories based on 
whether they were normal or 
abnormal. 1 = Normal, 2 = 
abnormal 
 















2.3.1. Outcome of Interest 
Our primary outcome of interest was lung cancer incidence, the primary variable 
used to distinguish case and control (see section 2.4, “Exclusion Criteria and Group 
Selection” below). Lung cancer incidence, while not an explicit variable itself, was 
derived from participant responses to the “Medical Conditions” questionnaire, a 
component of the Computer-Assisted Personal Interview (CAPI). The CAPI was 
given to participants who visited the mobile examination center (MEC) for a 
medical examination and consists of series of questions deemed too personal for the 
household interview portion of NHANES.  
2.3.2. Demographic Data 
Demographic variables of interest included age, gender, number of times seen a 
healthcare provider over the past year, and education level (Table 1). Age, Waist 
Circumference, Gender, and Education Level are variables based on questions found 
in the “Demographic Variables and Sample Weights” data file and are found in each 
survey cycle. Like lung cancer incidence, these variables are components of the 
CAPI but administered in the household of the participant. Selection of 
demographic variables was important for matching cases to controls, exclusion 
criteria, confounding, and evaluation of descriptive statistics. 
2.3.3. Dietary Data 
Dietary interview variables of interest included mean two-day vitamin A intakes 
(totals and subtypes), whether an individual’s diet differs from their reported 
interview intakes, mean essential fatty acid intakes, milk consumption, total dietary 
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fat, and saturated fat intakes, and usage of multivitamins/vitamin A-containing 
supplements. Variables associated with vitamin A intakes (and subtypes), essential 
fatty acid intakes, dietary fat intakes, and milk intakes are found in the “Dietary 
Interview” data files which contain food and nutrient records based on two 24-hr 
recalls (Table 1). The first 24-hr recall is conducted in person in a private room, at 
the MEC. A follow-up recall is then scheduled 3-10 days after the initial visit and 
conducted via telephone. The specific recall used in this setting is USDA’s (United 
States Department of Agriculture) Automated Multiple Pass Method (AMPM), a 
recall that is an effective method of reflecting individual nutrient intakes for energy, 
macronutrients, and micronutrients 27, 28. 
In the 03/04 and 05/06 cycles, individual supplement use was found in the dataset 
“Dietary Supplement Use 30-Day - File 2, Participant's Use of Supplements”. This 
dataset provided codes for each supplement the individual showed the interviewer 
during the 24-hr recall. The provided codes had to be matched to the specific 
supplement using the “Dietary Supplement Database - Ingredient Information” data 
file. This differed from the 07/08 cycles and beyond in that the supplement usage 
and database information were merged into one file, “Dietary Supplement Use 30 
Day - Individual Dietary Supplements” (Table 1). Dietary variables were selected 
based on our research questions, exclusion criteria when applicable, and the 
inclusion of potential confounders to our primary outcome.  
To ascertain whether participant recall data was like that of their usual intakes, we 
also were interested in the variable “Compare food consumed yesterday to usual” 
which allowed participants to address whether the amount of food they reported in 
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each of their recalls was like their normal intakes. This variable was found in the 
“Dietary Interview – Total Nutrient Intakes” files for each recall day and was 
categorized based on whether an individual consumed less than, as much as, or 
more than their 24-hr recall volume. By doing this, we hoped to increase the 
likelihood of recall data reflecting long-term dietary intakes/patterns. 
2.3.4. Cigarette Smoking Data 
Variables included whether an individual smoked cigarettes every day at the time of 
screening, amount of cigarettes smoked per day, age started smoking cigarettes, 
amount smoked per day when quit, and computed smoking duration. Importantly, 
some variables (such as computed smoking duration) had to be computed by 
combining other variables, as they were only available in some cycles vs others 
(Table 2). Separately, another variable of interest, “Household Smokers” was found 
in the “Smoking – Household Smokers” data file.  
2.3.5. Healthcare Data 
The variable “#times received healthcare over past year” is found in the “Hospital 
Utilization & Access to Care” data file and is also a component of the CAPI. This 
variable reports the number of times an individual has seen a healthcare provider 




2.4. Exclusion Criteria and Case/Control Assignment 
Our investigatory population consisted of 115,896 individuals across eight cycles of 
NHANES surveys (2003-2018), combined according to NHANES analytical guidelines 
(Johnson et al., 2013). Our reasoning for choosing cycles from these periods was based 
on the fact that before the 2003-2004 NHANES surveys, only one day of 24-hr dietary 
recalls was conducted. We thought that relying on dietary estimates from one 24-hr 
recalls to be truly reflective of long-term nutrient intakes would reduce the validity of 
our results. Importantly, NHANES recommends weighing survey data using the 
appropriate sample weights. Given our small sample size, as well as our case-control 
approach, we decided against weighing our data. While the assigned population weights 
designated to individuals by NHANES surveyors are meant to account for under-
sampling of populations subsets, our case-control approach matched a specific frequency 
of controls to our case group using well-defined exclusion and matching criteria. If we 
were to maintain usage of NHANES designated population sample weights, we would 
lose the matched population proportions derived through our case-control approach. 
Consequently, this would negate any of the substantial reduction in confounding bias 
enjoyed through our case-control study design 29.  
Variables of interest were identified then combined across cycles (Table 1). Using these 
variables, a framework for case/control membership was established and applied in two 
steps (Figure 1). The first step involved the construction of the “Case” group, identified 
initially as individuals with reported diagnoses of lung cancer per the MEC 
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questionnaire (Table 1). The second step involved the selection of eligible participants 
for the control group, followed by a 1:1 matching methodology.  
Figure 1 illustrates the assignment of individuals to the “case” group. Broadly, 
assignment to the “case” group was based on the presence of lung cancer; individuals 
who reported additional cancer diagnoses were not included as we believed such 
diagnoses could indicate that there was a chance the lung cancer was not derived 
organically and metastasized from another bodily location. After this initial selection, 
individuals who had never smoked cigarettes were removed from our sample, 
individuals who reported multivitamin/vitamin A-containing supplement usage were 
removed from the sample, individuals who reported unusual intakes during either of 
their dietary recall days and individuals with non-response to any variable important for 
our analyses (Table 1) and research question were excluded from the sample.  
The second step, or selection of participants from the control group, relied on an 
exclusion/selection process that slightly differed from the case group (Figure 1). Starting 
from the initial pool of the eight NHANES survey cycles, individuals who reported lung 
cancer or other types of cancer diagnoses were excluded from selection. Following this, 
individuals with non-response to key variables (Table 1) were excluded from 
consideration. Individuals were further excluded if they reported smoking at any 
frequency less than every day of the week. Final exclusions were made if an individual 
reported multivitamin or vitamin A-containing supplement use, individuals who reported 
unusual intakes during either of their dietary recall days, and if an individual had seen a 
healthcare provider less than two times during the previous year. The latter criteria were 
of particular importance to our outcome, as we posited that individuals who had reported 
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seeing their healthcare provider for two years or greater over the past year would have 
less likelihood of an undiagnosed case of lung cancer. 
Following the construction of the case group and the selection of eligible participants for 
the control group, 1:1 matching on key demographic/smoking variables was undertaken 
on a cycle-to-cycle basis. Starting with individuals with lung cancer in the 03-04 cycle, 
eligible individuals in the control pool (from the corresponding cycle) were matched on 
duration smoked, gender, and age. Duration of smoking was selected as the primary 
matching variable for several reasons. Firstly, lung cancer is a disease that often takes 
many years to develop and in an estimated 80-90% of cases, is the product of carcinogen 
exposure to the lungs 30. As such, we posited that matching on this basis would ensure 
similar lifetime exposure to smoke-based carcinogens. Further, recent evidence has 
shown that there is no significant difference between the predictive power of duration 
smoked (in years) and pack-years, the most used methodology of studying the 
relationship between cigarette smoking and respiratory disease pathophysiology 31. This 
was important to our study design, as the variable indicating the duration of time 
smoking a reported quantity of cigarettes was only available in the first half of the 
NHANES cycles which we were analyzing. Thus, it was impossible to compute a 
“Duration Smoked” variable based on the data available within all eight of our survey 
cycles. Another important consideration for matching on smoking habits was the amount 
smoked per day. Given the variability of this metric, the differences in the time of the 
experimental group from when they last smoked cigarettes and the predictive ability of 
“duration smoked” compared to other indices of cigarette-based lung cancer risk factors, 
it was determined that pack years would be a better overall variable to employ. For an 
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integrated overview of the exclusion criteria, selection framework, and research design, 
please see figure 1.  
2.5. Statistical Approach, Variable Coding, and Covariate Selection 
Several statistical approaches were employed to address our research question. 
Descriptive statistics were gathered on demographic variables, smoking characteristics, 
and nutrient intakes. Next, paired Samples T-tests were used to analyze differences in 
means of continuous variables between cases and matched controls. An exact McNemar 
test was used to assess significant differences in select categorical variable proportions 
between case and control. Further, conditional logistic regression was used to model the 
relationship between vitamin A sufficiency/insufficiency and lung cancer incidence in 
our sample.  
Paired Samples T-tests were used to analyze differences in mean total vitamin A and 
mean total vitamin A subtype intakes between individuals with lung cancer and 
individuals without lung cancer. As there were two 24-hr recall days that we derived 
participant nutrient intakes from, the mean total intakes for any nutrient analyzed had to 
be computed from each recall day. For an overview of this process as it pertains to 
vitamin A, subtypes of retinoids, and other nutrients of interest please see Table 2. 
Following this, the variable “Mean total vitamin A intakes” was coded into “sufficient” 
and “insufficient”, based on WHO recommendations for nutritional adequacy. Males and 
females consuming more than the baseline requirements (625 mcg and 500 mcg, 
respectively) were coded as “1” while those consuming less than baseline were coded as 
“2” 32. Differences in proportions of sufficiency/insufficiency were computed using an 
exact McNemar Test due to the case-control design of the study.  
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Next, conditional logistic regression was used to assess the likelihood of lung cancer 
incidence given vitamin A insufficiency considering confounders of known and 
exploratory clinical importance. As our study was a case-control design with a control 
group derived from participants matched on certain characteristics, Cox Regression was 
manipulated in a manner to produce a conditional logistic regression model 33. 
Covariates considered for analysis were “Age Started Smoking Cigarettes Regularly”, 
“Sufficient/Insufficient Vitamin A Intakes”, “Household Smokers (Yes/No)”, 
“Education Level”, “Drink Milk?”, “Calculated Omega 3:6 Fatty Acid Ratio”, “Waist 
Circumference”, “Mean Two-Day Dietary Fat Intakes”, and “Mean Two-Day Saturated 
Fat Intakes”. In many cases, continuous variables/covariates such as those found in the 
separate 24-hr recall files had to be combined and averaged to produce singular 
estimates. Further, independent variables with many levels were recoded to consist of a 
binary variable in which the responses aggregated many responses into certain brackets. 
This was both for organization and simplicity of analysis during conditional logistic 
regression (Table 2) 
Following selection and recoding of covariates, we sought to test our hypothesis that 
vitamin A insufficiency increased the likelihood of lung cancer using conditional logistic 
regression. Confounders (mentioned above) were analyzed independently and, using an 
effect size-based approach, were used to fit a model which retained our primary 
predictor of interest, “Sufficient/Insufficient Vitamin A Intakes”. Confounders were 
retained through both significance and modification of the coefficient of our predictor of 
interest. Outside of our hypothesis, conditional logistic regression was used to examine 
confounders from the previous model stage most predictive of lung cancer risk in our 
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sample, collectively. Univariate analysis of each predictor was conducted, and any 
predictors with a Wald statistic significant at the p = .25 level were aggregated into a 
preliminary model. Following this, a model was fit using repeated inclusion/exclusion of 
covariates and examining changes to both significances of the Wald Statistic and the 
effect sizes via the beta-coefficient 34.  
Before analyses were conducted, assumptions for each statistical approach were 
checked. Two-tailed significance for events was p = .05, except step-specific 
significance (described above) during logistic regression model fitting. Means were 
reported +/- the SD (Standard Deviation) for paired samples t-tests while ORs (Odds 
Ratios) were reported with 95% confidence intervals. Our analysis was performed using 
SPSS Version 27 35. 
3. Results 
3.1. Demographics and Smoking Characteristics  
Table 3 summarizes the demographic and smoking characteristics of individuals in our 
sample. Our sample consisted of more males (63.7%) males than females (36.3%). 
Across the sample, there were a greater number of smokers (64.3%) than non-smokers 
(35.7%). Importantly, around a quarter (28.6%) of individuals with lung cancer currently 
smoked cigarettes at the time of the survey while most (71.4%) were former smokers. 
All the matched controls were active, everyday smokers. Individuals with lung cancer 
were slightly older (M = 66.4, SD = 9.8) than those without lung cancer (M = 62.6, SD 
= 8.7). Male age (M = 67.2, SD = 10.3) was slightly greater than female age (M = 64.9, 
SD = 8.7). On average, smokers were older (M = 62.8, SD = 8.9) than non-smokers (M 
52 
 
= 72.83, SD = 7.75). On average, the age that those with lung cancer started smoking 
cigarettes (M = 17.4, SD = 3.9) was less than the age of those without lung cancer (M = 




















Sample-wide differences in total vitamin A intakes & subtypes  
 
Variable 
Sample-Wide Lung Cancer No Lung Cancer 
 
Mean Two-Day Total 
Vitamin A Intakes 
(mcg) 
 
M = 535.9, 
SD = 348.0 
 
M = 555.4, 
SD = 340.7 
 
M = 516.4, 
SD = 357.5 
 
Mean Two-Day Total 
Retinol Intakes (mcg) 
 
M = 378.8, 
SD =  274.7 
 
M = 382.5, 
SD = 33.2 
 
M = 375.1, 
SD = 44.8 
 




M = 2101.5, 
SD = 2745.2 
 
M = 2295.4, 
SD = 2518.4 
 
M = 1907.6, 
SD = 2745.2 
 




M = 130.0, 
SD =  288.2 
 
M = 97.8, 
SD = 21.0 
 
M = 162.3, 
SD = 54.3 
 




M = 290.3, 
SD = 538.5 
 
M = 312.7, 
SD = 62.4 
 
M = 267.9, 
SD = 89.7 
 




M = 1681.2, 
SD = 2214.0 
 
M = 1884.9, 
SD = 331.1 
 
M = 1477.4, 
SD = 301.4 
Note: M = “Mean”; SD = Standard Deviation. All reported values are in micrograms (mcg).  
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3.2. Two-Day Total Vitamin A Intakes, Retinol Intakes, Provitamin A Carotenoid Intakes, 
and Rates of Sufficiency/Insufficiency Do Not Differ Between Individuals with Lung 
Cancer and Cancer-Free, Matched Controls 
Mean two-day total vitamin A intakes from food were greater in men (M = 555.1, SD = 
356.8) then in women (M = 503.0, SD = 334.6). Mean two-day total vitamin A intakes 
from food were greater in non-smokers (M = 614.3, SD = 354.5) compared to smokers 
(M = 492.4, SD = 339.3). Sample-wide differences in total vitamin A intakes, as well as 
intakes of vitamin A subtypes, can be found in Table 3. A paired samples t-test showed 
no significant difference in Mean Two-Day Total Vitamin A Intakes between those 
diagnosed with lung cancer (Table 4). Additional paired samples t-tests showed no 
significant differences in mean intakes of retinol, total carotenoids, or subtypes of 
provitamin A carotenoids (Table 4). Next, individual Mean Two-Day Total Vitamin A 
Intakes were classified into a binary “Sufficient or Insufficient” variable as outlined in 
Table 2. An exact McNemar Test determined that there was no significant difference in 
the proportion of sufficient/insufficient vitamin A intakes between case and control (1, N 








































































































































































Note: t = “T-value”; df = “Degrees of Freedom”. All reported values are in micrograms (mcg). 
 



































3.3. Individuals With Lung Cancer Are More Likely to Consume Minimally Sufficient Intakes 
of Vitamin A Then Individuals Without Lung Cancer, Adjusting for Education Level, 
Waist Circumference, Age Started Smoking, Milk and EFA Intakes  
We used conditional logistic regression to test our hypothesis that vitamin A 
insufficiency increases the likelihood of lung cancer. Before adjustment for potential 
confounding, individuals with lung cancer were less likely to consume sufficient intakes 
of vitamin A (OR = 0.85, CI = 0.38 – 1.89), but this association was not significant. This 
was not surprising, as an exact McNemar Test determined that there was no statistically 
significant difference in the proportion of individuals with insufficient mean total 
Vitamin A intakes between case and controls (1, N = 49), p = .84. Adjusting for 
education, age of smoking initiation, Omega 6:3 Essential Fatty Acid Ratio, waist 
circumference, and milk consumption individuals with lung cancer were nearly 5.5 times 
more likely to consume minimally-sufficient amounts of vitamin A, compared to 
individuals without lung cancer (Table 5)  
3.4. Age Started Smoking Regularly, Household Smokers, Omega 6:3 Fatty Acid Ratio and 
Milk Consumption Are Predictors of Lung Cancer Risk in a Multivariate Conditional 
Logistic Regression Model 
Using conditional logistic regression, we sought to look at all predictors to assess which 
both univariately and multivariately best-predicted lung cancer incidence in our sample. 
Selected covariates that were univariately predictive of lung cancer at the preliminary p 
= .25 level were “Age started smoking cigarettes regularly”, “Does anyone smoke inside 
home?”, “Education Level”, “Milk Drinker?”, and “Calculated Omega 6:3 Fatty Acid 
Ratio” (Table 6). Next, a new model was fit as described in section 2.5, “Methods”. 
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After refitting our initial model several times to account for the effects of confounding 
covariates on coefficient values, variables with the greatest multivariate impact on lung 
cancer likelihood were “Age started smoking cigarettes regularly”, “Does anyone smoke 




















Model incorporating vitamin A sufficiency/insufficiency adjusted for education level, waist 
circumference, age started smoking, milk drinking, and omega 6:3 ratio  
 
 
 B SE Wald df Sig. Exp(B) 

































































































a Calculated Omega 

















Note. B = “Beta Coefficient”; SE = “Standard Error” associated with beta coefficient; Wald = 
“Wald Chi-Square Value”; df = “Degrees of Freedom”; Sig. = Significance of Wald Chi-Square 
Statistic; Exp(B) = “Odds Ratio”. 
a Covariates without units of measurement next to their name are categorical, except for 
“Calculated Omega 6:3 Fatty Acid Ratio”. This variable was derived by computing a ratio from 
Omega 3 fatty acid (gm) and Omega 6 fatty acid (gm). 







Univariate analysis of included covariates 
 
 B SE Wald df Sig. Exp(B) 





Vitamin A Intakes 
-.17 .41 .16 1 .68 .85 .53 2.64 
 
Age started smoking 
cigarettes regularly 
(years) 
-.34 .11 9.06 1 .003* .71 .57 .89 
 
Does anyone smoke 
inside home? 
.99 .44 5.10 1 .02* 2.71 1.14 6.46 
 


















a Calculated Omega 





































.87 .42 4.2 1 .04* 2.38 1.04 5.43 
 
Mean Two-Day 
Dietary Fat Intakes 
(gm) 
-.01 .01 .91 1 .34 .99 .98 1.01 
 
Meant Two-Day 
Saturated Fat Intakes 
(gm) 
 
-.01 .02 .29 1 .59 .99 .96 .102 
Note. B = “Beta Coefficient”; SE = “Standard Error” associated with beta coefficient; Wald = 
“Wald Chi-Square Value”; df = “Degrees of Freedom”; Sig. = Significance of Wald Chi-Square 
Statistic; Exp(B) = “Odds Ratio”. 
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a Covariates without units of measurement next to their name are categorical, except for 
“Calculated Omega 6:3 Fatty Acid Ratio”. This variable was derived by computing a ratio from 
Omega 3 fatty acid (gm) and Omega 6 fatty acid (gm). 
























Sample-specific predictive model for lung cancer incidence  
 
 B SE Wald df Sig. Exp(B) 
















































































Note. B = “Beta Coefficient”; SE = “Standard Error” associated with beta coefficient; Wald = 
“Wald Chi-Square Value”; df = “Degrees of Freedom”; Sig. = Significance of Wald Chi-Square 
Statistic; Exp(B) = “Odds Ratio”. 
a Covariates without units of measurement next to their name are categorical, except for 
“Calculated Omega 6:3 Fatty Acid Ratio”. This variable was derived by computing a ratio from 
Omega 3 fatty acid (gm) and Omega 6 fatty acid (gm). 








3.5. Milk Consumption Increases Odds of Lung Cancer Incidence 
Individuals who consumed any type of milk during one or both of their 24-hr recall days 
were nearly 2.5 times as likely to have lung cancer compared to those who reported no 
milk consumption (Table 6). The covariate also contributed a substantial amount of 
effect modification to both our vitamin A-dependent predictive model (Table 6). Given 
these results, we descriptively analyzed smoking, demographic, and dietary 
characteristics of milk drinkers in our sample to better understand any connections 
between our covariates and the outcome. Importantly, our research design was a case-
control study using pairwise matching; consequently, we were limited to comparisons of 
descriptive statistics between the groups and were not able to determine statistical 
significance. Caution should be taken when drawing conclusions from these results. 
Table 8 outlines comparative frequencies of smoking, demographic, and dietary 
characteristics between milk drinkers and non-milk drinkers. Notably, a greater 
percentage of non-milk drinkers were smokers (75.5%) compared to those who did drink 
milk (53.1%). Further, vitamin A insufficiency was greater in non-milk drinkers (71.4%) 
than milk drinkers (59.2%). Across continuous variables, characteristics of milk drinkers 
did not substantially differ from non-milk drinkers apart from mean two-day total 
vitamin A intakes and mean two-day total retinol intakes. Milk drinkers consumed more 
total vitamin A from food compared to non-milk drinkers, and more retinol from food 
compared to non-milk drinkers (Table 9) 
We further validated this result with data from the “Diet Behavior & Nutrition” 
questionnaire portion of the NHANES surveys. Using the variable “Past 30-day milk 
product consumption”, we created a variable that combined both this and the “Milk 
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Drinker?” variable. We called this variable “True Milk Drinkers”; individuals were 
considered a “True Milk Drinker” if they reported milk consumption from our original 
variable while additionally reporting either moderate to frequent milk consumption in 
the “Past 30-day milk product consumption” category. After this variable combination 
and recoding, we found that individuals who were both milk drinkers and moderate to 
frequent dairy consumers were nearly three times as likely to have lung cancer, 


















Comparisons of demographic, smoking, and dietary characteristics between those who do and 
do not drink milk 
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Mean Total Two-Day 
Carotenoid Intakes (mcg) 
 
49 2060.2 2714.4 2142.8 2565.8 
 
Calculated Omega 6:3 
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Frequencies of categorical demographic, smoking, and dietary variables in milk drinkers and 
non-milk drinkers  
 
Variable  Non-Milk Drinkers Milk Drinkers 
Sub-category N % N % 
 
Do you now smoke 
cigarettes Yes 
 
37 75.5% 26 53.1% 
  
No 12 24.5% 23 46.9% 
 
Sufficient/Insufficient 
Vitamin A Intakes Sufficient 14 28.6% 20 40.8% 
  
Insufficient 35 71.4% 29 59.2% 
 
Does anyone smoke 
inside the home? Yes 20 40.8% 22 44.9% 
  
No 29 59.2% 27 55.1% 
 
Education Level  30 61.2% 34 69.4% 
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high school 19 38.8% 15 30.6% 
 
Gender Male 31 63.3% 31 63.3% 
















In our case-control study examining vitamin A sufficiency/insufficiency and its impact on the 
likelihood of lung cancer incidence, we found that milk drinkers were nearly 2.5 times as 
likely to have been diagnosed with lung cancer, compared to those who reported no milk 
consumption. Contrary to our hypothesis, we found an increased association of lung cancer 
in individuals consuming minimally sufficient amounts of vitamin A, following adjustment 
for age of smoking initiation, omega 3:6 ratio, waist circumference, milk consumption, and 
education level. Between case and control, no significant differences in average two-day 
intakes of total vitamin A or subtypes were observed. 
The increased likelihood of lung cancer with milk consumption agrees with epidemiological 
evidence showing increased risk of lung cancer amongst current and former smokers who 
consume whole-fat dairy products 36-39. Nutrients in milk studied for their associations with 
lung cancer include dietary fat, vitamin D, retinol, and calcium; as retinol was a variable of 
interest in our design, we showed that differences in mean two-day intakes of retinol were 
not significantly different between case and control (Table 4). Compared to non-milk 
drinkers, milk drinkers consumed 25.0% more total vitamin A from the diet and 34.4% more 
total retinol from the diet. Given these findings, it may be plausible that our finding of 
vitamin A sufficiency’s impact on lung cancer likelihood is related to retinol in milk 
consumption. Due to the pairwise matching employed with our case-control design, however, 
we were unable to assess whether these differences were statistically significant. Further, we 




Supplemental dosages of retinol, in combination with beta-carotene, show positive 
associations with lung cancer risk; in the Beta-Carotene and Retinol Efficacy Trial (CARET), 
a large interventional trial used to reduce the risk of lung cancer through supplementation of 
retinoids, administration of a combination of high-dose beta-carotene and retinol 
significantly increased the likelihood of lung cancer 40. It was hypothesized that the 
supraphysiological dosage of carotenoids and vitamin A came in contact with oxidatively 
damaging components of cigarette smoke leading to the formation of biologically 
inert/dangerous retinoid byproducts, as well as antagonists to vitamin receptors. The 
administered dosage of retinol alone, however, was greater than 10 times the intakes of the 
case, control, milk drinkers, and non-milk drinkers in our sample. Consequently, the impact 
of milk consumption on the likelihood of lung cancer observed in our sample may be a 
product of other bioactive components of milk in tandem with or independent of retinol, even 
in those who were everyday smokers. 
Outside retinol, cow’s milk contains macronutrients and micronutrients known to impact 
lung cancer risk; such nutrients include fat, calcium and vitamin D. Saturated fat has been 
shown to increase the likelihood of lung cancer; in our sample, milk drinkers predominately 
consumed 2% or whole milk, suggesting that intakes of saturated fat may be greater in this 
subsample 41. Intakes of total dietary fat and saturated fat from food, however, were not 
independently associated with any significant increase or decrease in the likelihood of lung 
cancer incidence in our study, nor were they realized as contributing confounders to our final 
adjusted model. Further, no significant difference between mean total dietary fat and mean 
total saturated fat was found between case and control, and minimal differences in intakes 
between milk drinkers and non-milk drinkers were observed; the latter observation, however, 
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was not able to be tested for significance and caution should be given towards interpretation 
of this result. 
We did not calculate intakes of dietary vitamin D and calcium by each participant; as such, 
we cannot rule out residual confounding or influence by either of these micronutrients on 
lung cancer risk. High intakes of dietary vitamin D, but not circulating serum levels of 
vitamin D, were shown to reduce the risk of lung cancer in a meta-analysis that pooled 16 
different studies 42. Vitamin D has been shown to exhibit anticarcinogenic actions through its 
inhibition of signaling pathways including those that cause mutations in Wnt /β-catenin, 
epidermal growth factor receptor, and vascular endothelial growth factor; collectively these 
signaling pathways regulate cell proliferation, differentiation, genetic stability, apoptosis, and 
angiogenesis, and play a role in lung tumorigenesis. Further, vitamin D promotes cell cycle 
arrest via the cyclin-dependent kinase inhibitors p21 and p27; interestingly, mutations in 
these specific proteins are associated with lung cancer subtypes typical of non-smokers, 
suggesting vitamin D adequacy may play a role in preventing lung cancer in never-smokers 
43, 44.  
Calcium is another micronutrient that has been shown to have implications in lung 
carcinogenesis. Amongst early-stage lung cancer patients, low pre-diagnostic dietary calcium 
has been associated with poor survival while intakes of calcium, magnesium, and 
phosphorous are inversely associated with lung cancer in non-smokers 45, 46. Insufficient 
calcium intakes, particularly over long periods, can lead to activation of pathways implicated 
in tumor growth and metastasis such as IL-6 (Interleukin-6), Vascular Endothelial Growth 
Factor, and Macrophage Colony-stimulating Factor 46. Further, calcium insufficiency and 
subsequent increases in bone resorption increase the likelihood of tumor metastasis to the 
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bone; as an estimated 40% of metastatic lung cancer results in bone tumors, calcium 
sufficiency may be of particular importance to individuals with lung cancer, especially if they 
smoke cigarettes 46, 47. In contrast, intakes of calcium have also been shown to be associated 
with an increased risk of lung cancer, an effect which was made stronger when accounting 
for the effects of zinc and iron in the model; these associations were stronger in current 
smokers than former smokers 48. Apart from the latter study, however, these results are not in 
line with our finding that milk consumption increased the likelihood of lung cancer 
incidence, especially since milk is a rich source of both calcium and vitamin D. It should be 
noted, however, that since we did not calculate intakes of each micronutrient, we cannot 
conclude that these nutrients did not impact lung cancer likelihood in our sample. 
While milk drinking was strongly and independently associated with an increased incidence 
of lung cancer it was also a confounder in our adjusted model which retained our primary 
independent variable of interest, sufficient/insufficient mean two-day vitamin A intakes, to 
investigate its impact on lung cancer incidence. As previously discussed, while milk drinkers 
consumed 25.0% more total vitamin A from the diet and 34.4% more total retinol from the 
diet compared to non-milk drinkers, we were not able to determine whether such differences 
were statistically significant due to the design of our study. Further, the differences between 
intakes were not observably large in either category; as supraphysiological intakes of retinol 
and beta-carotene increased risk for lung cancer in smokers, an appreciably large intake of 
total vitamin A may be necessary to increase the risk of lung cancer, especially in the 
presence of cigarette smoke 40.  
As we were not able to rule out confounding effects from age of smoking initiation and the 
variable was independently and multivariately associated with an increased likelihood of 
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lung cancer incidence, the possibility of a diet-cigarette interaction should not be ruled out. 
Earlier smoking initiation, especially of cigarettes, increases the risk of smoking-related 
morbidities and all-cause mortality 49. Cigarette smoke has been shown to impact levels of 
vitamin A in the lung and increase the requirements for dietary vitamin E in humans 13, 50. 
Given the remarkably low levels of mean vitamin A intakes across both case and control, it 
may be that age of smoking initiation combined with poor nutrient intakes across the lifespan 
has a collectively carcinogenic effect. While we matched individuals on smoking duration 
and eliminated a likely source of variability in our findings, the confounding conferred by 
age of smoking initiation to our model and its interplay with lifetime intakes of certain 
nutrients warrants further investigation. 
We were not able to rule out confounding effects of waist circumference in our model; 
generally, increased waist circumference has been associated with an increased risk of a 
spectrum of chronic diseases, such as Coronary Artery Disease, Type II Diabetes, and 
Hypertension 51-53. Interestingly, increased waist circumference has also been associated with 
the risk of several forms of cancer, including lung cancer 54. While we did not calculate the 
caloric intake of participants in our study, abnormal waist circumference could be an 
indicator of overconsumption of calories, and consequently, a nutrient-poor diet 55. Thus, the 
impact of this covariate in our adjusted model on lung cancer risk could signify poor food 
choices, poor lifestyle choices, low nutrient intakes, and subsequent increased risk of chronic 
disease such as cancer. As there were no significant differences between mean two-day total 
vitamin A or vitamin A subtypes intakes between case and control, this result would make 
sense, particularly as only 20.4% of individuals in our sample consumed greater than or equal 
to gender-specific RDAs for vitamin A. As individuals in our case group had a proportionally 
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lower amount of individuals with abnormal waist circumferences, however, such a 
conclusion is not consistent with our findings. More research into energy intakes, waist 
circumference, abdominal obesity, micronutrients, and their collaborative impact on lung 
cancer risk is necessitated.  
We could not rule out confounding by the calculated Omega 6:3 essential fatty acid ratio in 
our adjusted model. Univariately, as the calculated Omega 6:3 essential fatty acid ratio 
increased in our sample, lung cancer was less likely. Omega 3 fatty acids can modulate 
inflammatory processes through antagonizing and inhibiting arachidonic acid-based 
inflammatory pathways 56. Further, Docosahexaenoic acid (DHA) and Eicosapentaenoic acid 
(EPA), which are synthesized from alpha-linolenic acid, have been shown to inhibit 
metastatic and growth pathways associated with lung cancer 57-59. As dietary antioxidants are 
thought to have an anti-inflammatory effect and be protective against lung cancer in both 
smokers and non-smokers, a synergistic protective effect between anti-inflammatory fatty 
acids and pro-vitamin A carotenoids would make sense 18, 19. A simultaneous reduction in 
lung cancer risk might be expected in such a scenario, but this was not illustrated by our 
findings.  
To our knowledge, our case-control approach was the first of its type to investigate vitamin A 
insufficiency and its impact on lung cancer incidence, using pairwise matching of case and 
control based on the duration of cigarette smoking. The strength of this design lies in this 
matching criteria, as smoking duration is an effective predictor of lung 31, 60, 61. Further, 
matching individuals in this manner allowed us to rule out a significant source of 
confounding concerning diet and lung cancer incidence. With this strength comes a few 
important weaknesses to our design. While we were able to rule out confounding by smoking 
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duration through our research design, we could not rule out residual confounding by smoking 
intensity. We did not include this variable as part of our exclusion criteria due to the 
proportionally greater number of former smokers in our “case” group, compared to current 
smokers. We believed that the introduction of such a variable could introduce a source of 
bias into our results, as the importance of smoking intensity would likely diminish as the time 
in years since quitting smoking in former smokers increased. Importantly, however, it has 
been shown that the duration of smoking in years is as good a predictor of lung 
carcinogenesis as both pack-year calculations and smoking intensity 31. 
Another weakness in our research design was that it relied on 24-hr recalls across two days to 
establish estimated nutrient intakes from foods. Thus, we could not rule out the potential for 
underreporting of foods when these recalls were conducted, especially as the second of the 
two recalls were conducted over the telephone. Further, we relied on participant’s accounts 
of whether their dietary recall reports were consistent with the usual amount/type of food that 
they consume. It should be noted, however, that we did control for supplemental intakes of 
vitamin A in our design through the exclusion of individuals who reported intakes of 
multivitamins or retinol-containing supplements. Thus, while potential underreporting of 
total dietary intakes of vitamin A could have occurred, the likelihood of reported intakes 
vastly exceeding reported amounts is unlikely. Further, the 24-hr recall methodology used 
during NHANES data collection has been shown to accurately estimate macronutrients, 
micronutrients, and energy from the diet 27, 28. Other weaknesses in our study include the 
small sample size, the retrospective design, overall poor reported intakes of vitamin A across 
our group, and reliance on participant-reported cases of lung cancer rather than clinically 
validated cases through electronic medical records or similar resources 
76 
 
In conclusion, the results of our case-control, exploratory study show a positive association 
between milk consumption and lung cancer, in current and former smokers. While sufficient 
vitamin A intakes were less likely in individuals with lung cancer, the crude OR was not 
significant. After adjustment for clinically/statistically important confounders, the association 
was reversed. As we could not rule out the confounding effects of smoking, milk 
consumption, and other important confounders and as total vitamin A was not significantly 
different between case and control, it may be that the effect conferred by vitamin A 
sufficiency on lung cancer risk is attributed by other nutritional components which were 
unmeasured in our study. As such, the increased vitamin A intake and their effects on lung 
cancer risk may be a surrogate marker for increased nutrients/energy elsewhere. Further, the 
relatively low levels of reported vitamin A intakes in our study compared to gender-specific 
RDAs may mean that the effects of vitamin A on lung cancer were too low across the 
sample. This may mean that a meaningful effect of sufficient vitamin A intakes on lung 
cancer likelihood may not have been possible to observe through our research design. 
Overall, our exploratory study is hypothesis-generating, and our major finding calls for 
further investigation into the role of nutrients and other bioactive components of milk (and 
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